Praxis am Markt

The program at Praxis am Markt investigates new treatments to reduce major cardiovascular events in patients with type 2 diabetes and atherosclerotic disease, while also exploring strategies for chronic kidney disease management.

• Evaluation of novel glucose‑lowering agents for cardiovascular safety
• Assessment of insulin alternatives in high‑risk diabetic populations
• Investigation of combination therapies to lower heart attack and stroke rates

By conducting these studies in Essen, Germany, the site contributes valuable data that can shape future cardiovascular guidelines.

Studies at this center focus on obesity, overweight, and type 2 diabetes, testing innovative agents that promote weight loss and improve metabolic health without requiring daily injections.

• Weight‑reduction trials using weekly injectable therapies
• Comparative effectiveness of new agents versus existing GLP‑1 analogues
• Impact of weight loss on glycemic control and cardiovascular risk

The work supports patients in Germany seeking sustainable solutions for metabolic disorders and informs clinical practice worldwide.

The site conducts research on chronic obstructive pulmonary disease (COPD), evaluating triple‑therapy inhalers to improve lung function and reduce severe cardiopulmonary events.

• Effectiveness of combined bronchodilator regimens
• Safety profiling of inhaled corticosteroids in COPD
• Assessment of cardiovascular outcomes linked to respiratory treatment

These investigations help refine COPD management strategies for patients across Europe, with Praxis am Markt providing a key recruitment hub.